Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Craig J. Currie. (2020) Scientific independence and objectivity: many questions linger about treatment of type 2 diabetes, such as scientific study design, optimal glucose control and the safety of injecting exogenous insulin. Postgraduate Medicine 132:8, pages 667-675.
Read now
Read now
Carlos E. Mendez, Rebekah J. Walker, Christian R. Eiler, Basem M. Mishriky & Leonard E. Egede. (2019) Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality. Postgraduate Medicine 131:6, pages 376-382.
Read now
Read now
Basem M. Mishriky, Doyle M. Cummings, Robert Tanenberg & Walter J. Pories. (2018) Re-examining insulin compared to non-insulin therapies for type 2 diabetes: when in the disease trajectory is insulin preferable?. Postgraduate Medicine 130:8, pages 653-659.
Read now
Read now
Articles from other publishers (12)
Rawayh Muslim Albaghlany, Mohammad Bagher Shahsavani, Masaru Hoshino, Ali Akbar Moosavi-Movahedi, Younes Ghasemi & Reza Yousefi. (2023) Optimizing expression, purification, structural and functional assessments of a novel dimeric incretin (GLP-1cpGLP-1). Biochimie.
Crossref
Crossref
Jingxing Liu & Xinhua Hu. (2022) Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis. Diabetes and Vascular Disease Research 19:3, pages 147916412210931.
Crossref
Crossref
Mark Lambie, Mario Bonomini, Simon J. Davies, Domenico Accili, Arduino Arduini & Victor Zammit. (2021) Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis. Trends in Endocrinology & Metabolism 32:9, pages 721-730.
Crossref
Crossref
Dale S. Edgerton, Mary C. Moore, Justin M. Gregory, Guillaume Kraft & Alan D. Cherrington. (2021) Importance of the route of insulin delivery to its control of glucose metabolism. American Journal of Physiology-Endocrinology and Metabolism 320:5, pages E891-E897.
Crossref
Crossref
Jennifer A. Wittwer, Sherita Hill Golden & Joshua J. Joseph. (2020) Diabetes and CVD Risk: Special Considerations in African Americans Related to Care. Current Cardiovascular Risk Reports 14:10.
Crossref
Crossref
Stephen H. Sinclair & Stanley S. Schwartz. (2019) Diabetic Retinopathy–An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes. Frontiers in Endocrinology 10.
Crossref
Crossref
Basem M. Mishriky, James R. Powell, Jennifer A. Wittwer, Jennifer X. Chu, Kerry A. Sewell, Qiang Wu & Doyle M. Cummings. (2019) Do GLP‐1RAs and SGLT‐2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism 21:10, pages 2274-2283.
Crossref
Crossref
Gary Scheiner, Stanley S. Schwartz & Mary E. Herman. (2018) Managing Diabetes by Maintaining Healthier Beta Cells: A Fresh Perspective for Diabetes Educators. AADE in Practice 6:4, pages 12-18.
Crossref
Crossref
David Levy. 2018. Practical Diabetes Care. Practical Diabetes Care
241
313
.
Mary E. Herman, James H. O'Keefe, David S.H. Bell & Stanley S. Schwartz. (2017) Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes. Progress in Cardiovascular Diseases 60:3, pages 422-434.
Crossref
Crossref
Edith M. Heintjes, Jetty A. Overbeek, Gillian C. Hall, Daniel Prieto-Alhambra, Francesco Lapi, Niklas Hammar & Irene D. Bezemer. (2017) Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries. Clinical Therapeutics 39:11, pages 2296-2310.e14.
Crossref
Crossref
Stanley S. Schwartz, Solomon Epstein, Barbara E. Corkey, Struan F.A. Grant, James R. Gavin III, Richard B. Aguilar & Mary E. Herman. (2017) A Unified Pathophysiological Construct of Diabetes and its Complications. Trends in Endocrinology & Metabolism 28:9, pages 645-655.
Crossref
Crossref